Recombinant Vmn1r45 is commercially produced for experimental studies. MyBioSource offers two variants:
Cell-Free Expression System: Host-free synthesis for structural studies .
Cellular Expression Systems: Optimized for functional assays in heterologous platforms .
Ligand Screening: Identifies pheromones and sulfated steroids activating V1R pathways .
Behavioral Studies: Knockout models (e.g., Vmn1r45<tm1a(KOMP)Mbp>) reveal impaired mating responses and stress dysregulation .
Neural Circuit Mapping: Calcium imaging shows dose-dependent activation in VNO neurons, with dynamic ranges spanning 3–4 log units .
Vmn1r45-expressing neurons exhibit narrow individual dynamic ranges but collectively detect ligands across broad concentrations:
| Ligand Type | Response Threshold | Max Activation | Citation |
|---|---|---|---|
| Sulfated estrogens | 10⁻¹⁰ M | 10⁻⁸–10⁻⁷ M | |
| ESP1 (exocrine peptide) | Not detected | – | |
| Glucuronidated steroids | 10⁻⁹ M | 10⁻⁷ M |
Bell-shaped dose-response curves suggest receptor saturation or desensitization at high ligand concentrations .
Mating Behavior: Female mice lacking Vmn1r45 homologs (e.g., ancV1R) reject male advances due to impaired pheromone detection .
Stress Response: Increased lateral septal neural activity correlates with social stress in knockout models .
Vmn1r45 belongs to an ancient V1R lineage conserved from fish to mammals . While mice retain ~187 functional V1Rs, humans retain only five pseudogenized remnants, reflecting divergent pheromone sensing strategies .
Current challenges include:
Heterologous Expression: Low yield in non-VNO systems complicates structural studies .
Ligand Discovery: Only 19/140 tested odorants activate human V1R homologs, suggesting undiscovered natural ligands .
Ongoing work focuses on CRISPR-engineered models and single-cell transcriptomics to map Vmn1r45’s role in social behavior circuits .